Document is current

Any future updates will be listed below

Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018

Crossref DOI link: https://doi.org/10.1007/s12325-022-02255-6

Published Online: 2022-08-30

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark